Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO02654) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Butane-1,4-diamine
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Drug in Phase 2 Clinical Trial
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=1045"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Beta-lactamase (blaB) | DME Info | Serratia marcescens | [1] | |||
| Arylamine N-acetyltransferase (NAT) | DME Info | Serratia marcescens | [1] | |||
| References | ||||||
| 1 | Long-chain 4-aminoquinolines as quorum sensing inhibitors in Serratia marcescens and Pseudomonas aeruginosa. ACS Chem Biol. 2017 May 19;12(5):1425-1434. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.